𝔖 Bobbio Scriptorium
✦   LIBER   ✦

HER-2/neu expression as a predictor of response to neoadjuvant docetaxel in patients with operable breast carcinoma

✍ Scribed by Peter A. Learn; I-Tien Yeh; Michelle McNutt; Gary B. Chisholm; Brad H. Pollock; Dennis L. Rousseau Jr.; Frances E. Sharkey; Anatolio B. Cruz; Morton S. Kahlenberg


Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
156 KB
Volume
103
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Correlation between HER-2 expression and
✍ Fan Zhang; Ying Yang; Terry Smith; Shu-Wan Kau; Judy M. McConathy; Francisco J. πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 89 KB πŸ‘ 2 views

## Abstract ## BACKGROUND The objective of this study was to determine whether HER‐2 overexpression is associated with improved response to neoadjuvant chemotherapy with 5‐fluorouracil, doxorubicin, cyclophosphamide (FAC) in patients with breast carcinoma. ## METHODS Ninety‐seven patients with S

Docetaxel plus epidoxorubicin as neoadju
✍ Andrea de Matteis; Francesco Nuzzo; Giuseppe D'Aiuto; Vincenzo Labonia; Gabriell πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 76 KB πŸ‘ 1 views

## Abstract ## BACKGROUND The objective of this study was to test the activity and toxicity of epirubicin plus docetaxel as primary chemotherapy for women with large, operable (T2; > 3 cm) or locally advanced (Stage III) breast carcinoma, including patients with inflammatory breast carcinoma. ##

Lack of association between amplificatio
✍ Ana M. Gonzalez-Angulo; Savitri Krishnamurthy; Yuko Yamamura; Kristine R. Brogli πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 138 KB πŸ‘ 1 views

## Abstract ## BACKGROUND The objective of the current study was to determine whether __her‐2__ amplification was associated with a pathologic response to preoperative chemotherapy with taxanes in patients with early‐stage breast carcinoma. ## METHODS The authors evaluated 71 patients treated fo